Christina Ruhlmann, Associate Professor at OUH Odense University Hospital and Principal Investigator at Danish Metastatic Melanoma Database (DAMMED), shared a post on LinkedIn:
“The survey on understanding the gaps in IO-toxicity management across European countries was presented today by Maggie O’Connor. I missed the prime time at the poster session but not the important key takeaways:
- Gaps in the knowledge on the usage of 2nd line immunosuppressants.
- A need for collaborative networks between oncologists and organ specialists for proper IO toxicity management
A huge thanks to the IO-tox ‘working group’ emerging from the ESMO Supportive care faculty and the Practising oncology work group.”
You can also read: ESMO 2025 Day 2 Highlights Not to Miss
